NPY1R Antibody (Center) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS: 1
- PROTOCOLS
- BACKGROUND
| Primary Accession | P25929 |
|---|---|
| Clone Names | 100430328 |
| Gene ID | 4886 |
|---|---|
| Other Names | Neuropeptide Y receptor type 1, NPY1-R, NPY1R, NPYR, NPYY1 |
| Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
| Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
| Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
| Name | NPY1R |
|---|---|
| Synonyms | NPYR, NPYY1 |
| Function | Receptor for neuropeptide Y and peptide YY. The rank order of affinity of this receptor for pancreatic polypeptides is NPY > [Pro-34] PYY, PYY and [Leu-31, Pro-34] NPY > NPY (2-36) > [Ile-31, Gln-34] PP and PYY (3-36) > PP > NPY free acid. |
| Cellular Location | Cell membrane; Multi-pass membrane protein. |

Provided below are standard protocols that you may find useful for product applications.
Background
Neuropeptide Y (NPY; MIM 162640) is one of the mostabundant neuropeptides in the mammalian nervous system and exhibitsa diverse range of important physiologic activities, includingeffects on psychomotor activity, food intake, regulation of centralendocrine secretion, and potent vasoactive effects on thecardiovascular system. Two major subtypes of NPY (Y1 and Y2) havebeen defined by pharmacologic criteria. NPY receptors, such asNPY1R, have been identified in a variety of tissues, includingbrain, spleen, small intestine, kidney, testis, placenta, andaortic smooth muscle (Herzog et al., 1992 [PubMed1321422]).
References
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Kim, H.Y., et al. BMB Rep 43(8):547-553(2010)Pinheiro, A.P., et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B (5), 1070-1080 (2010) :Naukkarinen, J., et al. PLoS Genet. 6 (6), E1000976 (2010) :Talmud, P.J., et al. Am. J. Hum. Genet. 85(5):628-642(2009)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.






Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.
